Pricing Log in Create free account

Mustang Bio, Inc. (MBIO) vs Silexion Therapeutics Corp (SLXN)

Mustang Bio, Inc. and Silexion Therapeutics Corp are both Biotechnology companies. Mustang Bio, Inc. and Silexion Therapeutics Corp are of similar size ($2.9M and $2.7M). Across the 8 metrics below, Mustang Bio, Inc. leads on 7 and Silexion Therapeutics Corp on 1.

Valuation

Metric MBIO SLXN Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.34 2.34 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.04 0.64
EV/Sales n/m n/m 9.21
Earnings yield (118.42%) (14,489.87%) (33.15%)
Free cash flow yield (147.00%) (12,070.84%) (25.50%)

Profitability

Metric MBIO SLXN Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (58.12%) (17,021.95%) (56.36%)
Return on assets (21.17%) (277.96%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MBIO SLXN Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 98.49% 97.73% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MBIO SLXN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.97 0.94 4.72
Net debt to EBITDA 7.22 0.38 0.96

Dividend

Metric MBIO SLXN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric MBIO SLXN Biotechnology median
Market cap 2.92m 2.73m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack